Shahidullah Jeffrey D, Roberts Holly, Parkhurst John, Ballard Rachel, Mautone Jennifer A, Carlson John S
Department of Psychiatry & Behavioral Sciences, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Department of Psychology, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Children (Basel). 2023 Aug 26;10(9):1454. doi: 10.3390/children10091454.
Psychotropic medications are commonly prescribed to school-aged youth for the management of mental health concerns. This paper describes the current state of evidence for psychotropic medications in school-aged youth. More specifically, the following sections summarize relevant medication research trials and practice parameters pertaining to psychotropic medication prescribing as well as the specific medications indicated for a range of commonly presenting disorders and symptom clusters in school-aged youth. For each of these disorders and symptom clusters, key findings pertaining to the current state of science and practice are highlighted for the purpose of offering patients, clinicians, researchers, and policymakers with nuanced considerations for the role of psychopharmacology within the context of a larger "whole-child" approach to care that relies on the collaboration of providers and services across systems of care to promote optimal child and family health and wellness. The paper concludes with a discussion about supporting the use of medication treatments in schools, including considerations for ensuring effective family-school-health system collaboration to best meet youth mental health needs.
精神药物常用于为学龄期青少年治疗心理健康问题。本文描述了学龄期青少年使用精神药物的现有证据状况。更具体地说,以下各节总结了与精神药物处方相关的药物研究试验和实践参数,以及针对学龄期青少年一系列常见疾病和症状群所适用的具体药物。对于这些疾病和症状群中的每一种,都突出了与当前科学和实践状况相关的关键发现,以便为患者、临床医生、研究人员和政策制定者提供细致入微的考虑因素,说明在更广泛的“全儿童”护理方法背景下精神药理学的作用,这种方法依赖于不同护理系统中提供者和服务之间的协作,以促进儿童和家庭的最佳健康状态。本文最后讨论了在学校支持药物治疗的使用,包括确保有效的家庭 - 学校 - 健康系统协作以最好地满足青少年心理健康需求的考虑因素。